June 23, 2024

chemistry fume hoods in a typical modern chemistry laboratory

Bo Shen/iStock via Getty Images

XBiotech Inc. (NASDAQ:XBIT) has been able to complete recruitment for a few studies already, and it has initiated another one targeting patients with Rheumatoid arthritis [RA]. Natrunix is being developed to treat patients with RA and


Leave a Reply

Your email address will not be published. Required fields are marked *